Physician profile
Mark A Starnes
NPI 1114470366
$10,989.60
in general payments reported to CMS, 2019-2025
41 companies · $2,294 in 2025
The $2,294 reported for 2025 was more than what 85% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,305 · 2020: $1,051 · 2021: $1,521 · 2022: $1,205 · 2023: $1,653 · 2024: $1,961 · 2025: $2,294.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,905 · Education: $2.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,904.76 |
| Education | $2.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,062.37 | 2019-2025 | Lux-Dx Insertable Cardiac Monitor, Watchman Access System, General - Therapies |
| Abbott Laboratories | $1,525.37 | 2019-2025 | Xience Skypoint, Esprit, Cardiomems |
| Shockwave Medical, INC | $861.69 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Janssen Pharmaceuticals, INC | $667.98 | 2019-2024 | Xarelto |
| Pfizer INC. | $622.64 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $543.43 | 2022-2025 | |
| Cardiovascular Systems INC. | $476.18 | 2019-2022 | |
| Abiomed | $394.10 | 2021-2024 | Impella |
| Amgen INC. | $324.08 | 2019-2025 | Repatha, Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $305.50 | 2023-2025 | Jardiance |
| Angiodynamics, INC. | $295.68 | 2024 | Auryon Laser System 100-120 Vac |
| Medtronic Vascular, INC. | $235.11 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $226.63 | 2020-2025 | Farxiga |
| Scpharmaceuticals INC. | $224.89 | 2024-2025 | |
| Bard Peripheral Vascular, INC. | $193.88 | 2023-2024 | Rotarexs 6 F X 135 Cm, Crosser Iq |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $167.00 | 2020-2023 | |
| Terumo Medical Corporation | $161.95 | 2019-2021 | |
| Actelion Pharmaceuticals US, INC. | $145.19 | 2020-2025 | Opsumit |
| E.R. Squibb & Sons, L.L.C. | $136.68 | 2023-2025 | Camzyos, Eliquis |
| Merck Sharp & Dohme LLC | $123.62 | 2023-2024 | Verquvo |
| Bayer Healthcare Pharmaceuticals INC. | $123.43 | 2024-2025 | |
| Bolton Medical INC | $119.79 | 2021 | |
| Livanova USA, INC. | $108.71 | 2023 | Lifesparc |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $98.31 | 2019-2025 | Lifevest |
| Inari Medical, INC. | $96.03 | 2022-2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Lexicon Pharmaceuticals, INC. | $84.27 | 2024 | |
| Alnylam Pharmaceuticals INC. | $80.45 | 2024-2025 | Onpattro |
| Novo Nordisk INC | $79.41 | 2024-2025 | Wegovy, Ozempic |
| Esperion Therapeutics, INC. | $67.22 | 2024-2025 | Nexletol |
| Kiniksa Pharmaceuticals International, Plc | $57.34 | 2024 | Arcalyst |
| Cardiva Medical, INC. | $51.39 | 2025 | Savvywire, Optowire |
| Cardinal Health 200 LLC | $50.57 | 2020 | |
| Kestra Medical Technology Services, INC. | $47.36 | 2025 | Assure Wcd |
| Biosense Webster, INC. | $46.36 | 2025 | Carto 3 |
| Edwards Lifesciences Corporation | $37.86 | 2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Vital Connect, INC | $37.23 | 2023-2025 | Vitalpatch Rtm |
| Lantheus Medical Imaging, INC. | $29.85 | 2021 | |
| Daiichi Sankyo INC. | $26.86 | 2024 | Injectafer |
| United Therapeutics Corporation | $22.81 | 2025 | Tyvaso |
| Sobi, INC | $15.90 | 2022 | |
| Baxter Healthcare | $14.48 | 2025 | Hillrom - Cardiac Ambulatory Monitor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Starnes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.